Olga Arkadievna Obukhova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olga Arkadievna Obukhova has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
- Ildar Anvarovich Kurmukov
Peoples' Friendship University of Russia
28 shared publications - Grigory S. Yunaev
N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
9 shared publications - Anastasia Sergeevna Ivanova
State Scientific Centre of Coloproctology
7 shared publications Юнаев Григорий Сергеевич
ГБУЗ Московской области «Видновская клиническая больница
6 shared publications- Natalya Yu. Shagina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
5 shared publications - Aleksandra M. Stepanova
Federal Scientific and Clinical Center of Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency of Russia
3 shared publications
Latest Publications
- Open Access
- 26 August 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 121-131
Effectiveness of a semi-elemental formula as part of complex therapy for chronic diarrhea in patients with gastric cancer who have completed antitumor treatment
BACKGROUND: Radical antitumor treatment of gastric cancer can lead to chronic diarrhea. Therefore, the choice of the type of enteral formula for nutritional support becomes important. AIM: To compare the effectiveness of semi-elemental and standard polymeric formulas in the post-discharge period in patients with gastric cancer after gastrectomy. METHODS: A retrospective, non-randomized, single-center study included patients older than 18 years who had undergone gastrectomy, completed antitumor treatment, had no signs of progression of the underlying disease, and had chronic diarrhea. At the initial consultation, patients received detailed instructions on the nature and composition of their diet, as well as recommendations for additional intake of probiotics, multi-enzyme preparations, and sipping (500 mL per day) of semi-elemental or polymeric formulas at the patient's discretion. At the follow-up consultation after 28 days, patients were divided into two groups depending on the type of formula they chose. Patients receiving the semi-elemental formula were included in the study group (SG); those receiving polymeric formulas, in the control group (CG). The dynamics of diarrhea and indicators of nutritional and functional status were analyzed. The results are presented as mean ± standard deviation. RESULTS: A total of 113 patients with gastric cancer (65 men) were examined. Fifty-five patients took the semi-elemental formula, and 58 took various polymeric formulas. During the observation period, the frequency of defecation was significantly lower in the SG than in the CG (2.05 ± 1.43 vs. 2.61 ± 1.46 times, p = 0.04). In the SG, body weight, serum total protein concentration, and absolute lymphocyte count were higher than in the CG: 64.23 ± 10.33 vs. 63.56 ± 8.6 kg; 68.61 ± 2.37 vs. 67.78 ± 4.46 g/L; 2.33 ± 0.4 vs. 2.15 ± 0.43 × 10⁹/L, p 0.05, respectively. Functional status according to the Eastern Cooperative Oncology Group (ECOG) scale, handgrip strength, and anxiety and depression levels were better in the SG (0.89 ± 0.6 vs. 1.17 ± 0.75 points; 33.51 ± 10.09 vs. 29.66 ± 9.58 kg; 6.44 ± 1.24 vs. 7.09 ± 1.61 points; 8.27 ± 1.62 vs. 8.86 ± 1.3 points, p 0.05, respectively). CONCLUSION: In patients with gastric cancer who completed antitumor treatment, the use of a semi-elemental enteral formula as additional nutrition had advantages over standard polymeric formulas.
- 26 August 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 121-131
Open AccessEffectiveness of a semi-elemental formula as part of complex therapy for chronic diarrhea in patients with gastric cancer who have completed antitumor treatment
BACKGROUND: Radical antitumor treatment of gastric cancer can lead to chronic diarrhea. Therefore, the choice of the type of enteral formula for nutritional support becomes important. AIM: To compare the effectiveness of semi-elemental and standard polymeric formulas in the post-discharge period in patients with gastric cancer after gastrectomy. METHODS: A retrospective, non-randomized, single-center study included patients older than 18 years who had undergone gastrectomy, completed antitumor treatment, had no signs of progression of the underlying disease, and had chronic diarrhea. At the initial consultation, patients received detailed instructions on the nature and composition of their diet, as well as recommendations for additional intake of probiotics, multi-enzyme preparations, and sipping (500 mL per day) of semi-elemental or polymeric formulas at the patient's discretion. At the follow-up consultation after 28 days, patients were divided into two groups depending on the type of formula they chose. Patients receiving the semi-elemental formula were included in the study group (SG); those receiving polymeric formulas, in the control group (CG). The dynamics of diarrhea and indicators of nutritional and functional status were analyzed. The results are presented as mean ± standard deviation. RESULTS: A total of 113 patients with gastric cancer (65 men) were examined. Fifty-five patients took the semi-elemental formula, and 58 took various polymeric formulas. During the observation period, the frequency of defecation was significantly lower in the SG than in the CG (2.05 ± 1.43 vs. 2.61 ± 1.46 times, p = 0.04). In the SG, body weight, serum total protein concentration, and absolute lymphocyte count were higher than in the CG: 64.23 ± 10.33 vs. 63.56 ± 8.6 kg; 68.61 ± 2.37 vs. 67.78 ± 4.46 g/L; 2.33 ± 0.4 vs. 2.15 ± 0.43 × 10⁹/L, p 0.05, respectively. Functional status according to the Eastern Cooperative Oncology Group (ECOG) scale, handgrip strength, and anxiety and depression levels were better in the SG (0.89 ± 0.6 vs. 1.17 ± 0.75 points; 33.51 ± 10.09 vs. 29.66 ± 9.58 kg; 6.44 ± 1.24 vs. 7.09 ± 1.61 points; 8.27 ± 1.62 vs. 8.86 ± 1.3 points, p 0.05, respectively). CONCLUSION: In patients with gastric cancer who completed antitumor treatment, the use of a semi-elemental enteral formula as additional nutrition had advantages over standard polymeric formulas.
- Open Access
- 16 August 2026
- Published by IRBIS in Journal of Medical Rehabilitation
- Vol. 4 (2) , 79-94
Сonceptual model and system of performance indicators for medical rehabilitation in the Russian Federation
Background. Although regulatory requirements for assessing the efficiency of medical rehabilitation have been established in the Russian Federation, a unified, conceptually structured system of indicators consistent with international frameworks still needs to be developed. Due to the disparity of indicators across departments, regional data become difficult to compare and further integrate into international monitoring. Objective: To develop a conceptual model and matrix of basic indicators that evaluate the performance of the medical rehabilitation system in the Russian Federation by integrating the Donabedian model, the International Classification of Functioning, Disability, and Health (ICF), and framework documents from the World Health Organization (WHO). Material and methods. A targeted documentary and literature review was conducted that examined the Russian regulations (GOST R 58258-2018 and GOST R 58259-2018); the 2024 methodological recommendations of the Federal Bureau of Medical and Social Expertise; the 2019 WHO documents “Rehabilitation in Health Systems: Guide for Action” and “Rehabilitation Indicator Menu” (RIM). Fifteen key publications on conceptual frameworks for assessing the quality of rehabilitation were also examined. Content analysis and coding were conducted according to Donabedian model, ICF domains, and system level. Results. While the Russian healthcare regulatory framework has structural and effective elements, it lacks process indicators and planned monitoring of rehabilitation coverage. Three critical gaps were identified in the comparison with RIM, including the absence of patient-centered outcomes as a mandatory component, economic indicators, and national-level coverage monitoring. A conceptual, three-layer model was developed based on the Donabedian model, the ICF domain, and the system level. A matrix of 20 basic indicators was proposed, involving 5 structural, 7 process, and 8 outcome indicators. Сonclusion. The proposed conceptual model creates a systematic basis for monitoring the efficiency of medical rehabilitation in the Russian Federation and provides conditions for harmonizing national data with international WHO standards.
- 16 August 2026
- Published by IRBIS in Journal of Medical Rehabilitation
- Vol. 4 (2) , 79-94
Open AccessСonceptual model and system of performance indicators for medical rehabilitation in the Russian Federation
Background. Although regulatory requirements for assessing the efficiency of medical rehabilitation have been established in the Russian Federation, a unified, conceptually structured system of indicators consistent with international frameworks still needs to be developed. Due to the disparity of indicators across departments, regional data become difficult to compare and further integrate into international monitoring. Objective: To develop a conceptual model and matrix of basic indicators that evaluate the performance of the medical rehabilitation system in the Russian Federation by integrating the Donabedian model, the International Classification of Functioning, Disability, and Health (ICF), and framework documents from the World Health Organization (WHO). Material and methods. A targeted documentary and literature review was conducted that examined the Russian regulations (GOST R 58258-2018 and GOST R 58259-2018); the 2024 methodological recommendations of the Federal Bureau of Medical and Social Expertise; the 2019 WHO documents “Rehabilitation in Health Systems: Guide for Action” and “Rehabilitation Indicator Menu” (RIM). Fifteen key publications on conceptual frameworks for assessing the quality of rehabilitation were also examined. Content analysis and coding were conducted according to Donabedian model, ICF domains, and system level. Results. While the Russian healthcare regulatory framework has structural and effective elements, it lacks process indicators and planned monitoring of rehabilitation coverage. Three critical gaps were identified in the comparison with RIM, including the absence of patient-centered outcomes as a mandatory component, economic indicators, and national-level coverage monitoring. A conceptual, three-layer model was developed based on the Donabedian model, the ICF domain, and the system level. A matrix of 20 basic indicators was proposed, involving 5 structural, 7 process, and 8 outcome indicators. Сonclusion. The proposed conceptual model creates a systematic basis for monitoring the efficiency of medical rehabilitation in the Russian Federation and provides conditions for harmonizing national data with international WHO standards.
- Open Access
- 24 July 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 132-139
Perioperative medicine: what do you need to know about new hypoglycemic drugs?
In recent years, glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic polypeptide receptor agonists, and sodium-glucose cotransporter 2 inhibitors have been increasingly used to treat diabetes mellitus, heart failure, and cardiometabolic syndrome. Their use is associated with the development of gastrostasis, which significantly increases the risk of perioperative aspiration and explains the increased attention anesthesiologists pay to this problem. Euglycemic or diabetic ketoacidosis may also develop. We searched PubMed, Web of Science, and eLibrary for the period 2016–2026 using the keywords “агонисты рецепторов глюкагоноподобного пептида-1” (glucagon-like peptide-1 receptor agonists), “агонисты рецепторов глюкагоноподобного пептида-1 и глюкозозависимого инсулинотропного полипептида” (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists), “ингибиторы натрий-глюкозного котранспортёра 2-го типа” (sodium-glucose cotransporter 2 inhibitors), “анестезия” (anesthesia), “аспирация” (aspiration), and “регургитация” (regurgitation). The drug-induced slowing of gastric motility must be taken into account during anesthesia. A large body of clinical data has demonstrated that the drugs in question significantly increase the risk of aspiration and regurgitation. However, the timing of drug withdrawal before anesthesia, the regimens for resuming treatment, and the conditions for emergency anesthesia remain unclear. Current international guidelines suggest varying timing of drug withdrawal before anesthesia, recommend paying attention to characteristic dyspeptic symptoms, justify the need for gastric ultrasound if a large residual volume is suspected, and recommend a “full stomach” protocol during emergency interventions. Currently, there are no valid guidelines for the perioperative care of such patients in the Russian Federation. The steady increase in the number of patients receiving new hypoglycemic drugs requires an individualized approach to anesthesia, as well as the development of Russian clinical guidelines for the perioperative care of this patient population. Our proposed algorithm could form the basis for such guidelines, improving the safety of general anesthesia.
- 24 July 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 132-139
Open AccessPerioperative medicine: what do you need to know about new hypoglycemic drugs?
In recent years, glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic polypeptide receptor agonists, and sodium-glucose cotransporter 2 inhibitors have been increasingly used to treat diabetes mellitus, heart failure, and cardiometabolic syndrome. Their use is associated with the development of gastrostasis, which significantly increases the risk of perioperative aspiration and explains the increased attention anesthesiologists pay to this problem. Euglycemic or diabetic ketoacidosis may also develop. We searched PubMed, Web of Science, and eLibrary for the period 2016–2026 using the keywords “агонисты рецепторов глюкагоноподобного пептида-1” (glucagon-like peptide-1 receptor agonists), “агонисты рецепторов глюкагоноподобного пептида-1 и глюкозозависимого инсулинотропного полипептида” (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists), “ингибиторы натрий-глюкозного котранспортёра 2-го типа” (sodium-glucose cotransporter 2 inhibitors), “анестезия” (anesthesia), “аспирация” (aspiration), and “регургитация” (regurgitation). The drug-induced slowing of gastric motility must be taken into account during anesthesia. A large body of clinical data has demonstrated that the drugs in question significantly increase the risk of aspiration and regurgitation. However, the timing of drug withdrawal before anesthesia, the regimens for resuming treatment, and the conditions for emergency anesthesia remain unclear. Current international guidelines suggest varying timing of drug withdrawal before anesthesia, recommend paying attention to characteristic dyspeptic symptoms, justify the need for gastric ultrasound if a large residual volume is suspected, and recommend a “full stomach” protocol during emergency interventions. Currently, there are no valid guidelines for the perioperative care of such patients in the Russian Federation. The steady increase in the number of patients receiving new hypoglycemic drugs requires an individualized approach to anesthesia, as well as the development of Russian clinical guidelines for the perioperative care of this patient population. Our proposed algorithm could form the basis for such guidelines, improving the safety of general anesthesia.
- Open Access
- 17 July 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 111-120
Effect of exposure duration to xenon at 0.5 minimum alveolar concentration on the concentration of S100b protein after ischemic brain injury
BACKGROUND: Ischemic stroke remains a significant problem. To date, there are no clinically proven treatments that specifically prevent or limit neuronal death due to ischemic injury. In this regard, the use of xenon appears promising, since it has a neuroprotective effect; however, its mechanism of action is not fully understood. AIM: To determine the effect of xenon at 0.5 minimum alveolar concentration (MAC) at different exposure times on the concentration of S100b protein in blood serum after ischemic brain injury in rats in an experiment. METHODS: To determine the effect of xenon at 0.5 MAC on the concentration of the neuron-specific protein S100b in blood serum, cerebral ischemia was modeled followed by reperfusion using the Long method in 50 male Wistar rats. After blood flow restoration, animals in the control group received an oxygen-air mixture, while animals in the study groups received xenon at 0.5 MAC at exposures of 30, 60, and 120 minutes. The comparison group consisted of sham-operated animals. To determine the concentration of S100b protein, venous blood was collected on days 1, 3, and 7 of the study from the caudal vein. The concentration of S100b protein in the post-ischemic period was determined using enzyme-linked immunosorbent assay. RESULTS: It was established that in animals of the control group, the concentration of S100b protein increased 12-fold (p = 0.0001) on day 1 relative to that in the comparison group and decreased over 7 days by only 3.4-fold (p = 0.001). Inhalation of xenon at 0.5 MAC with a 30-minute exposure had no significant effect on S100b concentration compared to the control group. Inhalation of xenon at 0.5 MAC with exposures of 60 and 120 minutes reduced S100b concentration on days 1 and 7 of the postoperative period by 2-fold compared to the control group and brought it closer to the level in sham-operated animals. CONCLUSION: Exposure to xenon at 0.5 MAC for 60 and 120 minutes led to a significant decrease in serum S100b concentration already on the first day. By day 7 of observation, serum S100b concentrations did not differ between the group of sham-operated animals and the study group of animals receiving xenon at 0.5 MAC at exposures of 60 and 120 minutes.
- 17 July 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (3) , 111-120
Open AccessEffect of exposure duration to xenon at 0.5 minimum alveolar concentration on the concentration of S100b protein after ischemic brain injury
BACKGROUND: Ischemic stroke remains a significant problem. To date, there are no clinically proven treatments that specifically prevent or limit neuronal death due to ischemic injury. In this regard, the use of xenon appears promising, since it has a neuroprotective effect; however, its mechanism of action is not fully understood. AIM: To determine the effect of xenon at 0.5 minimum alveolar concentration (MAC) at different exposure times on the concentration of S100b protein in blood serum after ischemic brain injury in rats in an experiment. METHODS: To determine the effect of xenon at 0.5 MAC on the concentration of the neuron-specific protein S100b in blood serum, cerebral ischemia was modeled followed by reperfusion using the Long method in 50 male Wistar rats. After blood flow restoration, animals in the control group received an oxygen-air mixture, while animals in the study groups received xenon at 0.5 MAC at exposures of 30, 60, and 120 minutes. The comparison group consisted of sham-operated animals. To determine the concentration of S100b protein, venous blood was collected on days 1, 3, and 7 of the study from the caudal vein. The concentration of S100b protein in the post-ischemic period was determined using enzyme-linked immunosorbent assay. RESULTS: It was established that in animals of the control group, the concentration of S100b protein increased 12-fold (p = 0.0001) on day 1 relative to that in the comparison group and decreased over 7 days by only 3.4-fold (p = 0.001). Inhalation of xenon at 0.5 MAC with a 30-minute exposure had no significant effect on S100b concentration compared to the control group. Inhalation of xenon at 0.5 MAC with exposures of 60 and 120 minutes reduced S100b concentration on days 1 and 7 of the postoperative period by 2-fold compared to the control group and brought it closer to the level in sham-operated animals. CONCLUSION: Exposure to xenon at 0.5 MAC for 60 and 120 minutes led to a significant decrease in serum S100b concentration already on the first day. By day 7 of observation, serum S100b concentrations did not differ between the group of sham-operated animals and the study group of animals receiving xenon at 0.5 MAC at exposures of 60 and 120 minutes.
- Open Access
- 4 May 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (2) , 93-99
Correction of metabolic disorders in the early period of total pancreatectomy, or "Ordnung muss sein": A case report
The frequency of total pancreatectomy has recently increased, but most Russian clinics have limited experience managing patients in the apancreatic state. Sudden loss of pancreatic endocrine function leads to pancreatogenic insulin-dependent diabetes mellitus type 3c, while exocrine insufficiency impairs the digestion and absorption of nutrients, primarily fats. Clinics with extensive experience treating patients after total pancreatectomy effectively address glycemic control by developing and implementing insulin therapy protocols, while nutritional deficiencies are addressed with adequate enzyme replacement therapy. We present a clinical case of a patient without preexisting diabetes who underwent total pancreatectomy for pancreatic cancer. Postoperatively, continuous intravenous insulin was administered in the intensive care unit. Adequate doses were titrated throughout the day to maintain moderate hyperglycemia. Mixed nutritional support and pancreatic enzyme supplementation were initiated. On the fourth postoperative day, the patient was transferred to the surgical ward. However, 12 hours later, he was readmitted to the intensive care unit with severe diarrhea and hyperglycemia, which was controlled, and the pancreatic enzyme dose was increased. After stabilization, on the sixth postoperative day, he was transferred to a surgical ward, where insulin and pancreatic enzyme replacement therapy was selected. He was discharged from the surgical ward on the 15th day in satisfactory condition. This clinical case demonstrates the need to implement protocols for the management of patients after total pancreatectomy in Russian clinical practice. This will allow for the timely diagnosis and prevention of sharp fluctuations in glucose levels in these patients, significantly reducing the incidence of complications and mortality in the early postoperative period.
- 4 May 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (2) , 93-99
Open AccessCorrection of metabolic disorders in the early period of total pancreatectomy, or "Ordnung muss sein": A case report
The frequency of total pancreatectomy has recently increased, but most Russian clinics have limited experience managing patients in the apancreatic state. Sudden loss of pancreatic endocrine function leads to pancreatogenic insulin-dependent diabetes mellitus type 3c, while exocrine insufficiency impairs the digestion and absorption of nutrients, primarily fats. Clinics with extensive experience treating patients after total pancreatectomy effectively address glycemic control by developing and implementing insulin therapy protocols, while nutritional deficiencies are addressed with adequate enzyme replacement therapy. We present a clinical case of a patient without preexisting diabetes who underwent total pancreatectomy for pancreatic cancer. Postoperatively, continuous intravenous insulin was administered in the intensive care unit. Adequate doses were titrated throughout the day to maintain moderate hyperglycemia. Mixed nutritional support and pancreatic enzyme supplementation were initiated. On the fourth postoperative day, the patient was transferred to the surgical ward. However, 12 hours later, he was readmitted to the intensive care unit with severe diarrhea and hyperglycemia, which was controlled, and the pancreatic enzyme dose was increased. After stabilization, on the sixth postoperative day, he was transferred to a surgical ward, where insulin and pancreatic enzyme replacement therapy was selected. He was discharged from the surgical ward on the 15th day in satisfactory condition. This clinical case demonstrates the need to implement protocols for the management of patients after total pancreatectomy in Russian clinical practice. This will allow for the timely diagnosis and prevention of sharp fluctuations in glucose levels in these patients, significantly reducing the incidence of complications and mortality in the early postoperative period.
- 16 April 2026
- Published by IRBIS in Journal of Medical Rehabilitation
- Vol. 3 (4) , 289-292
Resolution of the section “Open Talk: The Paradigm of Rehabilitation in Women's Health” at the 9th Russian Congress with International Participation on Physical and Rehabilitation Medicine (December 15–16, 2025)
At the “Open Talk: The Paradigm of Rehabilitation in Women's Health” section held during the 9th Russian Congress on Physical and Rehabilitation Medicine, experts agreed that the paradigm of women's rehabilitation should fundamentally change. Rehabilitation practices for women with medical conditions related to oncology and obstetrics and gynecology need to be personalized, scientifically based, and focused on quality of life, rather than relying on traditional approaches. The International Classification of Functioning, Disabilities, and Health (ICF) is one of key tools of the new paradigm. The ICF allows for a standardized assessment of patients' physical, psycho-emotional, and social conditions, as well as the establishment of measurable goals. The resolution defines priority tasks for scientific, medical, and educational institutions, including implementing a multidisciplinary approach, developing clinical guidelines, training specialists in the use of the ICF, and establishing an expert council to further develop this direction.
- 16 April 2026
- Published by IRBIS in Journal of Medical Rehabilitation
- Vol. 3 (4) , 289-292
Resolution of the section “Open Talk: The Paradigm of Rehabilitation in Women's Health” at the 9th Russian Congress with International Participation on Physical and Rehabilitation Medicine (December 15–16, 2025)
At the “Open Talk: The Paradigm of Rehabilitation in Women's Health” section held during the 9th Russian Congress on Physical and Rehabilitation Medicine, experts agreed that the paradigm of women's rehabilitation should fundamentally change. Rehabilitation practices for women with medical conditions related to oncology and obstetrics and gynecology need to be personalized, scientifically based, and focused on quality of life, rather than relying on traditional approaches. The International Classification of Functioning, Disabilities, and Health (ICF) is one of key tools of the new paradigm. The ICF allows for a standardized assessment of patients' physical, psycho-emotional, and social conditions, as well as the establishment of measurable goals. The resolution defines priority tasks for scientific, medical, and educational institutions, including implementing a multidisciplinary approach, developing clinical guidelines, training specialists in the use of the ICF, and establishing an expert council to further develop this direction.
- Open Access
- 20 March 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (1) , 30-38
Impact of lipid intake on lithogenic metabolic parameters in urolithiasis
BACKGROUND: The global incidence of urolithiasis and obesity has been increasing, particularly in countries adopting a Western lifestyle. However, the role of dietary lipids in the development of urolithiasis remains insufficiently studied. AIM: This work aimed to assess the impact of total fat, saturated fatty acids, and cholesterol intake on biochemical parameters of lithogenic metabolism in patients with urolithiasis. METHODS: For a comprehensive assessment of dietary patterns, patients with urolithiasis were surveyed using an original questionnaire program. The questionnaire addressed the consumption of various food groups. Data on the chemical composition of foods were obtained from publicly available sources. Daily intake of fats, saturated fatty acids, and cholesterol was calculated based on reported consumption. Foods consumed more than once per month were included in the analysis. To evaluate lithogenic metabolism, serum and 24-hour urine levels of total calcium, phosphorus, urea, creatinine, chloride, magnesium, and uric acid were measured. The mineral composition of urinary calculi was determined by infrared spectroscopy using a reference spectral library of known stone composition. Patients were stratified according to stone composition (calcium oxalate, uric acid, and calcium phosphate). Comparative analysis of the mean intake of the studied nutrients and the associations between intake levels of fats, saturated fatty acids, and cholesterol and biochemical parameters of blood and urine was performed in these patient groups. Statistical analysis was conducted using Statistica 12.0 (StatSoft, USA) with parametric methods, including correlation analysis and the Student t test for independent samples. A significance level of p ≤ 0.05 was applied. RESULTS: A total of 140 patients with urolithiasis were included: 67 men (47.9%) and 73 women (52.1%), aged 19 to 73 years. Stone composition was determined in all patients: calcium oxalate stones in 68 (48.6%), uric acid stones in 18 (12.9%), calcium phosphate stones in 44 (31.4%), and struvite stones in 10 (7.1%). In the overall cohort, mean intake of saturated fatty acids and cholesterol exceeded recommended levels: 37.82 ± 1.23 g and 347.98 ± 13.95 mg per day, respectively. No differences in intake between men and women were observed. High cholesterol intake had the greatest impact on metabolic parameters across most stone types. CONCLUSIONS: Lipid intake may influence lithogenic metabolism depending on the chemical composition of urinary stones. When prescribing dietary interventions aimed at reducing intake of fats, saturated fatty acids, and cholesterol, the chemical composition of urinary stones should be taken into account.
- 20 March 2026
- Published by ECO-Vector LLC (Publications) in Clinical nutrition and metabolism
- Vol. 7 (1) , 30-38
Open AccessImpact of lipid intake on lithogenic metabolic parameters in urolithiasis
BACKGROUND: The global incidence of urolithiasis and obesity has been increasing, particularly in countries adopting a Western lifestyle. However, the role of dietary lipids in the development of urolithiasis remains insufficiently studied. AIM: This work aimed to assess the impact of total fat, saturated fatty acids, and cholesterol intake on biochemical parameters of lithogenic metabolism in patients with urolithiasis. METHODS: For a comprehensive assessment of dietary patterns, patients with urolithiasis were surveyed using an original questionnaire program. The questionnaire addressed the consumption of various food groups. Data on the chemical composition of foods were obtained from publicly available sources. Daily intake of fats, saturated fatty acids, and cholesterol was calculated based on reported consumption. Foods consumed more than once per month were included in the analysis. To evaluate lithogenic metabolism, serum and 24-hour urine levels of total calcium, phosphorus, urea, creatinine, chloride, magnesium, and uric acid were measured. The mineral composition of urinary calculi was determined by infrared spectroscopy using a reference spectral library of known stone composition. Patients were stratified according to stone composition (calcium oxalate, uric acid, and calcium phosphate). Comparative analysis of the mean intake of the studied nutrients and the associations between intake levels of fats, saturated fatty acids, and cholesterol and biochemical parameters of blood and urine was performed in these patient groups. Statistical analysis was conducted using Statistica 12.0 (StatSoft, USA) with parametric methods, including correlation analysis and the Student t test for independent samples. A significance level of p ≤ 0.05 was applied. RESULTS: A total of 140 patients with urolithiasis were included: 67 men (47.9%) and 73 women (52.1%), aged 19 to 73 years. Stone composition was determined in all patients: calcium oxalate stones in 68 (48.6%), uric acid stones in 18 (12.9%), calcium phosphate stones in 44 (31.4%), and struvite stones in 10 (7.1%). In the overall cohort, mean intake of saturated fatty acids and cholesterol exceeded recommended levels: 37.82 ± 1.23 g and 347.98 ± 13.95 mg per day, respectively. No differences in intake between men and women were observed. High cholesterol intake had the greatest impact on metabolic parameters across most stone types. CONCLUSIONS: Lipid intake may influence lithogenic metabolism depending on the chemical composition of urinary stones. When prescribing dietary interventions aimed at reducing intake of fats, saturated fatty acids, and cholesterol, the chemical composition of urinary stones should be taken into account.
- Open Access
- 26 December 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (4) , 169-180
Eating behavior patterns in patients after abdominal cancer
BACKGROUND: Eating behavior disorders in patients with an intestinal stoma after radical treatment of colorectal or gastric cancer represent a serious problem affecting quality of life and nutritional status. AIM: This study aimed to determine the distribution and key factors of eating behavior disorders in patients after abdominal oncologic surgery depending on the presence of an intestinal stoma. METHODS: A cross-sectional comparative study included 30 patients divided into two comparable groups: 15 patients with an intestinal stoma and 15 patients without a stoma. Data collection involved a set of methods: the SCOFF questionnaire (Sick, Control, One stone, Fat, Food) for screening eating disorders; the Hospital Anxiety and Depression Scale (HADS); and a semi-structured interview. RESULTS: Patients with a stoma demonstrated a significantly higher prevalence of SCOFF-positive screening results (60% vs 20%; p = 0.020), clinically relevant anxiety (53.3% vs 13.3%; p = 0.020), and depression (33.3% vs 6.7%; p = 0.069). Qualitative analysis in stoma patients revealed a predominance of fear of somatic consequences (93.3%), strict dietary restrictions (86.7%), food anhedonia (80.0%), and avoidant behavior (80.0%). Multivariate regression analysis identified the main predictors of eating behavior disorders, namely body image disturbance (β = −3.15; p 0.001), fear of social catastrophe (β = −2.80; p 0.001), and nutritional deficiency (β = −2.25; p = 0.001). This model explained 68% of the variance in eating behavior disorders (R² = 0.68; p 0.001). CONCLUSION: Eating behavior disorders in patients with an intestinal stoma have a complex biopsychosocial nature. Rehabilitation requires a multidisciplinary approach including psychological correction of body image disturbances, social anxiety, and nutritional support.
- 26 December 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (4) , 169-180
Open AccessEating behavior patterns in patients after abdominal cancer
BACKGROUND: Eating behavior disorders in patients with an intestinal stoma after radical treatment of colorectal or gastric cancer represent a serious problem affecting quality of life and nutritional status. AIM: This study aimed to determine the distribution and key factors of eating behavior disorders in patients after abdominal oncologic surgery depending on the presence of an intestinal stoma. METHODS: A cross-sectional comparative study included 30 patients divided into two comparable groups: 15 patients with an intestinal stoma and 15 patients without a stoma. Data collection involved a set of methods: the SCOFF questionnaire (Sick, Control, One stone, Fat, Food) for screening eating disorders; the Hospital Anxiety and Depression Scale (HADS); and a semi-structured interview. RESULTS: Patients with a stoma demonstrated a significantly higher prevalence of SCOFF-positive screening results (60% vs 20%; p = 0.020), clinically relevant anxiety (53.3% vs 13.3%; p = 0.020), and depression (33.3% vs 6.7%; p = 0.069). Qualitative analysis in stoma patients revealed a predominance of fear of somatic consequences (93.3%), strict dietary restrictions (86.7%), food anhedonia (80.0%), and avoidant behavior (80.0%). Multivariate regression analysis identified the main predictors of eating behavior disorders, namely body image disturbance (β = −3.15; p 0.001), fear of social catastrophe (β = −2.80; p 0.001), and nutritional deficiency (β = −2.25; p = 0.001). This model explained 68% of the variance in eating behavior disorders (R² = 0.68; p 0.001). CONCLUSION: Eating behavior disorders in patients with an intestinal stoma have a complex biopsychosocial nature. Rehabilitation requires a multidisciplinary approach including psychological correction of body image disturbances, social anxiety, and nutritional support.
- Open Access
- 10 December 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (3) , 128-138
Justification and safety of “anti-cancer diets”: a review
Alternative diets have become widely used by patients with cancer, most of whom choose these diets on their own. The shortage of specialists with equal expertise in oncology, nutritional science, and gastroenterology contributes to an increase in self-medication and reliance on unqualified practitioners and unverified online sources. Therefore, evaluating the most popular diets is an urgent task. This work aimed to evaluate the validity of the most popular alternative diets as part of a combined supportive treatment strategy for patients with cancer, based on a review of publications. The following keywords were used to search relevant publications in PubMed and e-Library databases for the past 20 years: диета против рака (anti-cancer diet), альтернативная диета (alternative diet), рак (cancer), комплементарные методы лечения (complementary therapies), and клинические рекомендации (clinical guidelines). Based on the obtained data, the most popular diets in oncology practice are: the ketogenic diet, the Mediterranean diet, the Gerson diet, the Budwig diet, and the Breuss diet. We evaluated their compositions and effects on disease prevention, carcinogenesis, and overall survival. The justification and safety of prescribing these dietary regimens were considered. The data showed that the ketogenic and Mediterranean diets were the most extensively studied. Although the ketogenic diet is based on Warburg hypothesis, it does not have a significant antitumor effect. Moreover, some clinical studies have reported its carcinogenic potential. The Mediterranean diet is shown to be effective in preventing cancer, rather than its treatment. The Gerson, Budwig, and Breuss diets contradict fundamental principles of carcinogenesis and have no evidence base. Therefore, it is crucial to follow the nutritional support recommendations developed by international and Russian professional communities. These recommendations are based on substantial clinical data and sufficient evidence and prohibit risky diets for patients with cancer.
- 10 December 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (3) , 128-138
Open AccessJustification and safety of “anti-cancer diets”: a review
Alternative diets have become widely used by patients with cancer, most of whom choose these diets on their own. The shortage of specialists with equal expertise in oncology, nutritional science, and gastroenterology contributes to an increase in self-medication and reliance on unqualified practitioners and unverified online sources. Therefore, evaluating the most popular diets is an urgent task. This work aimed to evaluate the validity of the most popular alternative diets as part of a combined supportive treatment strategy for patients with cancer, based on a review of publications. The following keywords were used to search relevant publications in PubMed and e-Library databases for the past 20 years: диета против рака (anti-cancer diet), альтернативная диета (alternative diet), рак (cancer), комплементарные методы лечения (complementary therapies), and клинические рекомендации (clinical guidelines). Based on the obtained data, the most popular diets in oncology practice are: the ketogenic diet, the Mediterranean diet, the Gerson diet, the Budwig diet, and the Breuss diet. We evaluated their compositions and effects on disease prevention, carcinogenesis, and overall survival. The justification and safety of prescribing these dietary regimens were considered. The data showed that the ketogenic and Mediterranean diets were the most extensively studied. Although the ketogenic diet is based on Warburg hypothesis, it does not have a significant antitumor effect. Moreover, some clinical studies have reported its carcinogenic potential. The Mediterranean diet is shown to be effective in preventing cancer, rather than its treatment. The Gerson, Budwig, and Breuss diets contradict fundamental principles of carcinogenesis and have no evidence base. Therefore, it is crucial to follow the nutritional support recommendations developed by international and Russian professional communities. These recommendations are based on substantial clinical data and sufficient evidence and prohibit risky diets for patients with cancer.
- Open Access
- 21 November 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (3) , 116-127
The parenteral use of alanyl-glutamine reduces the duration of severe, antibiotic-associated diarrhea in patients with cancer
BACKGROUND: Antibiotic-associated diarrhea can lead to hypovolemia, which requires intensive care. AIM: This study aimed to evaluate the effectiveness of parenteral use of alanyl-glutamine as part of combined therapy for treating acute, severe, antibiotic-associated diarrhea in hospitalized patients with cancer. METHODS: A total of 60 patients (32 men; age range: 58–72 years) were evaluated. The study included patients who developed grade 4 diarrhea (10 times per day) within 2–8 weeks after receiving antibacterial therapy. The diarrhea was not caused by drug-induced mucositis, and was complicated by dehydration. Patients were randomized into two groups. After the water-electrolyte balance was restored, all patients received total parenteral nutrition. The patients in the study group received additional intravenous alanyl-glutamine at 0.4 g/kg of body weight once daily in days 1 to 14. Enteral nutrition was added when bowel movements decreased to 3–4 times daily. On day 8, total parenteral nutrition was discontinued, and a special diet was prescribed with enteral nutrition for three days. On day 11, enteral nutrition was replaced by probiotic dietary treatment. Laboratory testing included fecal bacteriological tests for Clostridium difficile toxins A and B, and pathogenic intestinal bacteria. The following parameters were assessed at admission and on day 14: severity score using the Acute Physiology and Chronic Health Evaluation II (APACHE II) scale, body mass index, concentrations of total protein, albumin, and electrolytes, liver function tests, azotemia parameters, the duration of diarrhea (defined as ≥4 bowel movements per day), and the recurrence rate over 56 days. A statistical analysis was performed using Microsoft Excel 2011. The results are expressed as the mean ± standard deviation (M ± SD). The two-tailed Student t-test and the Fisher exact test were used to assess statistical differences. RESULTS: The APACHE II scores at admission did not differ between the study and control groups: 11.2 ± 2.8 vs 10.9 ± 2.3, p 0.05. The duration of diarrhea was significantly shorter in the study group than in the control group: 3.72 ± 0.48 days vs 6.47 ± 1.14 days, p = 0.03. The recurrence rate in the study group was also significantly lower than in the control group: 6.67% vs 30.0%, p = 0.04. CONCLUSION: Dipeptide glutamine (alanyl-glutamine) as part of combined intensive care improves the duration and recurrence rate of antibiotic-associated diarrhea in patients with cancer.
- 21 November 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 6 (3) , 116-127
Open AccessThe parenteral use of alanyl-glutamine reduces the duration of severe, antibiotic-associated diarrhea in patients with cancer
BACKGROUND: Antibiotic-associated diarrhea can lead to hypovolemia, which requires intensive care. AIM: This study aimed to evaluate the effectiveness of parenteral use of alanyl-glutamine as part of combined therapy for treating acute, severe, antibiotic-associated diarrhea in hospitalized patients with cancer. METHODS: A total of 60 patients (32 men; age range: 58–72 years) were evaluated. The study included patients who developed grade 4 diarrhea (10 times per day) within 2–8 weeks after receiving antibacterial therapy. The diarrhea was not caused by drug-induced mucositis, and was complicated by dehydration. Patients were randomized into two groups. After the water-electrolyte balance was restored, all patients received total parenteral nutrition. The patients in the study group received additional intravenous alanyl-glutamine at 0.4 g/kg of body weight once daily in days 1 to 14. Enteral nutrition was added when bowel movements decreased to 3–4 times daily. On day 8, total parenteral nutrition was discontinued, and a special diet was prescribed with enteral nutrition for three days. On day 11, enteral nutrition was replaced by probiotic dietary treatment. Laboratory testing included fecal bacteriological tests for Clostridium difficile toxins A and B, and pathogenic intestinal bacteria. The following parameters were assessed at admission and on day 14: severity score using the Acute Physiology and Chronic Health Evaluation II (APACHE II) scale, body mass index, concentrations of total protein, albumin, and electrolytes, liver function tests, azotemia parameters, the duration of diarrhea (defined as ≥4 bowel movements per day), and the recurrence rate over 56 days. A statistical analysis was performed using Microsoft Excel 2011. The results are expressed as the mean ± standard deviation (M ± SD). The two-tailed Student t-test and the Fisher exact test were used to assess statistical differences. RESULTS: The APACHE II scores at admission did not differ between the study and control groups: 11.2 ± 2.8 vs 10.9 ± 2.3, p 0.05. The duration of diarrhea was significantly shorter in the study group than in the control group: 3.72 ± 0.48 days vs 6.47 ± 1.14 days, p = 0.03. The recurrence rate in the study group was also significantly lower than in the control group: 6.67% vs 30.0%, p = 0.04. CONCLUSION: Dipeptide glutamine (alanyl-glutamine) as part of combined intensive care improves the duration and recurrence rate of antibiotic-associated diarrhea in patients with cancer.